Similar articles

• Interaction of phenylbutazone and tolbutamide in man.

  Szita M, Gachályi B, Tornyossy M, Káldor A. Szita M, et al. Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):378-80. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 7450929
• Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.

  Pond SM, Birkett DJ, Wade DN. Pond SM, et al. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):573-9. doi: 10.1002/cpt1977225part1573. Clin Pharmacol Ther. 1977. PMID: 913025
• [Interaction of salicyl compounds and other non-steroidal anti-inflammatory agents: pharmacokinetic study of phenylbutazone-aspirin combination in man].

  Gaucher A, Netter P, Faure G, Tamisier JN, Pourel J, Maillard A, Royer RJ. Gaucher A, et al. Rev Rhum Mal Osteoartic. 1976 Jun;43(6):425-9. Rev Rhum Mal Osteoartic. 1976. PMID: 781789 Clinical Trial. French.
• Genetic and environmental factors affecting drug response in man.

  Vesell ES. Vesell ES. Fed Proc. 1972 Jul-Aug;31(4):1253-69. Fed Proc. 1972. PMID: 4114107 Review. No abstract available.
• [Protein binding of biologically active substances and the therapeutic significance of its modification].

  Meyer FP, Walther H. Meyer FP, et al. Z Arztl Fortbild (Jena). 1974 Jul 15;68(14):690-5. Z Arztl Fortbild (Jena). 1974. PMID: 4140627 Review. German. No abstract available.